Work as a PhD is exciting as well as challenging at the best of times. But in the present time of the COVID-19 crisis and social distancing, you can be confronted with additional restrictions for your research and personal life.
This is why Radboud University launches a new initiative, called Global PhD Support. This program matches national and international PhD candidates with a ‘buddy’, someone who is personally assigned to them. Besides providing a social connection, a buddy can help the PhD candidate with first-line support and information on various topics such as mental health, housing, legal matters etc. For more severe issues there is a whole team of experts behind the buddy to help out with questions or issues you may have. They can also refer you to a professional for further help and support, when necessary.
Having a buddy can be a valuable asset, especially in times of social distancing, uncertainty, and being isolated from relatives and friends.
If you sign up, your buddy will schedule an intake meeting through an online platform (e.g. Skype or Zoom). This intake will be the first of a maximum of ten support sessions of 45 minutes at the most, which will take place once a week.
Are you a(n external) PhD candidate at Radboud University or Radboud University Medical Center? This service is open to any PhD candidate affiliated with Radboud University and Radboud University Medical Center, regardless of your country of origin.
Sign up here.
Questions?If you have any further questions, please send an e-mail to email@example.com.
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes17 September 2020
Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.read more
Annette Schenck appointed professor of Translational Genetics17 September 2020
Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients17 September 2020
Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.read more
Radboudumc does large-scale research on systemic sclerosis10 September 2020
In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.read more